Liu Yang et al. proved that TIMP1 mRNA levels are higher in platelets from CRC patients than in platelets from healthy volunteers, suggesting that it may be used as a diagnostic biomarker for CRC [225]. Here, TIMP1 is linked to colorectal carcinoma.